Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells

Endocrinology

Volumn 140, Issue 5, 1999, Pages 2183-2190

  Katsuyama, Koichi ^a   Shichiri, Masayoshi ^a   Kato, Hiroki ^a   Imai, Taihei ^a   Marumo, Fumiaki ^a   Hirata, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; HORMONAL REGULATION; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0033306816     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.5.6718     Document Type: Article

References (49)

1. Nitric oxide: Physiology, pathophysiology, and pharmacology
2. Nitric oxide as a secretory product of mammalian cells
3. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP
4. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells
5. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion
6. Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon γ and lipopolysaccharide
7. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide
8. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκB-α: A mechanism for NF-κB activation
9. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
10. Immuno-suppression by glucocorticoids: Inhibition of NF-κB activity through induction of lκB synthesis
11. Role of transcriptional activation of IκB-α in mediation of immunosuppression by glucocorticoids
12. Glucocorticoid-mediated repression of NF-κB activity in endothelial cells does not involve induction of IκB-α synthesis
13. Inhibition of NF-κB by sodium salicylate and aspirin
14. 2+ / calmodulin -sensitive tyrosine kinase
15. L-arginine infusion induces hypotension and increases diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in human
16. Role of nuclear factor-kappa-B activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells
17. Molecular cloning of the rat inducible nitric oxide synthase gene promoter
18. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
19. Molecular cloning of endothelial, inducible nitric oxide synthase gene from rat aortic endothelial cell
20. Biphasic regulation of the preproendothelin-1 gene by c-Myc
21. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme
22. Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis
23. Role of transcription factor NF-κB/ Rel in induction of nitric oxide synthase
24. Induction and stabilization of I κB-α by nitric oxide mediates inhibition of NF-κB
25. In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-κB
26. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes
27. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells
28. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1β-stimulated mesangial cells: Evidence for the involvement of transcriptional and posttranscriptional regulation
29. Nicotinamide and dexamethasone inhibit interleukin-1-induced nitric oxide production by RINm5F cells without decreasing messenger ribonucleic acid expression for nitric oxide synthase
30. Transforming growth factor-β1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleuldn-1β in rat smooth muscle cells
31. Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydro-biopterin synthesis and L-arginine transport
32. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids
33. Molecular mechanisms of anti-inflammatory action of glucocorticoids
34. Mechanism of gene expression by the glucocorticoid receptor: Role of protein-protein interactions
35. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
36. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
37. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation
38. Signal-induced site-specific phosphorylation targets IκB-α to the ubiquitin-proteasome pathway
39. Dexamethasone suppresses iNOS gene expression by up-regulating I-κB-α and inhibiting NF -κB
40. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-κB
41. Non-steroidal anti-inflammatory drug gastropathy: Causes and treatment
42. Chemokine gene expression in bone marrow stromal cells: Downregulation with sodium salicylate
43. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation
44. The mode of action of aspirin-like drugs: Effect on inducible nitric oxide synthase
45. The anti-inflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1β at a translational step, but not at a transcriptional step, in hepatocytes
46. Effects of aspirin on nitric oxide formation and de novo protein synthesis by RINm5F cells and rat islets
47. Salicylate is a transcriptional inhibitor of the inducible nitric oxide synthase in cultured cardiac fibroblasts
48. Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts
49. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase